A

Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408

Watchlist Manager
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Watchlist
Price: 12.51 CNY 2.04% Market Closed
Market Cap: 5B CNY
Have any thoughts about
Anhui Huaren Health Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Anhui Huaren Health Pharmaceutical Co Ltd stock under the Base Case scenario is 10.59 CNY. Compared to the current market price of 12.51 CNY, Anhui Huaren Health Pharmaceutical Co Ltd is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
10.59 CNY
Overvaluation 15%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation Backtest
Anhui Huaren Health Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Anhui Huaren Health Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Anhui Huaren Health Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Anhui Huaren Health Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Anhui Huaren Health Pharmaceutical Co Ltd.

What unique competitive advantages
does Anhui Huaren Health Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Anhui Huaren Health Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide P/S
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide P/E
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide P/OCF
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide P/FCFE
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide P/B
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide EV/S
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide EV/GP
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide EV/EBIT
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide EV/OCF
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide EV/FCFF
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide EV/IC
for Anhui Huaren Health Pharmaceutical Co Ltd.

Compare the intrinsic valuations
of Anhui Huaren Health Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Anhui Huaren Health Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Anhui Huaren Health Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Anhui Huaren Health Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Anhui Huaren Health Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Anhui Huaren Health Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide ROE
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide ROA
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide ROIC
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide ROCE
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide Gross Margin
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide Operating Margin
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide Net Margin
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide FCF Margin
for Anhui Huaren Health Pharmaceutical Co Ltd.

Show all solvency ratios
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide D/E Ratio
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide D/A Ratio
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide Quick Ratio
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide Current Ratio
for Anhui Huaren Health Pharmaceutical Co Ltd.

Provide Cash Ratio
for Anhui Huaren Health Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Anhui Huaren Health Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Anhui Huaren Health Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Anhui Huaren Health Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Anhui Huaren Health Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Anhui Huaren Health Pharmaceutical Co Ltd

Balance Sheet Decomposition
Anhui Huaren Health Pharmaceutical Co Ltd

Current Assets 2.8B
Cash & Short-Term Investments 593.1m
Receivables 559.8m
Other Current Assets 1.7B
Non-Current Assets 1.8B
Long-Term Investments 94.7m
PP&E 870.1m
Intangibles 671.8m
Other Non-Current Assets 148.7m
Current Liabilities 2B
Accounts Payable 252.9m
Accrued Liabilities 57.4m
Short-Term Debt 1.3B
Other Current Liabilities 306.5m
Non-Current Liabilities 704.4m
Long-Term Debt 568.8m
Other Non-Current Liabilities 135.6m
Efficiency

Earnings Waterfall
Anhui Huaren Health Pharmaceutical Co Ltd

Revenue
4.1B CNY
Cost of Revenue
-2.8B CNY
Gross Profit
1.2B CNY
Operating Expenses
-1B CNY
Operating Income
200.6m CNY
Other Expenses
-67.7m CNY
Net Income
133m CNY

Free Cash Flow Analysis
Anhui Huaren Health Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Anhui Huaren Health Pharmaceutical Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive 3-Year Average ROE
Positive ROE
49/100
Profitability
Score

Anhui Huaren Health Pharmaceutical Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Anhui Huaren Health Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
Low D/E
50/100
Solvency
Score

Anhui Huaren Health Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Anhui Huaren Health Pharmaceutical Co Ltd

There are no price targets for Anhui Huaren Health Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Anhui Huaren Health Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Anhui Huaren Health Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Anhui Huaren Health Pharmaceutical Co Ltd

Country

China

Industry

Retail

Market Cap

5B CNY

Dividend Yield

0.8%

Description

Anhui Huaren Health Pharmaceutical Co., Ltd. engages in pharmaceutical distribution. The company is headquartered in Hefei, Anhui and currently employs 5,785 full-time employees. The company went IPO on 2023-03-01. The pharmaceutical retail business is mainly engaged in the sales of medicines, health food and medical equipment, as well as the diagnosis and treatment of common diseases. The agency business mainly promotes and sells to downstream pharmaceutical retail enterprises. The terminal centralized procurement business mainly provides one-stop distribution services for individual pharmacies and small chain retail terminals.

Contact

ANHUI
Hefei
No. 18 Shanghai Road, Baohe Industrial Zone
+8655162862668
www.hrjkjt.com

IPO

2023-03-01

Employees

5 785

Officers

CFO, Secretary & Accounting Supervisor
Ms. Mei Li
Deputy General Manager & Director
Mr. Jun Yin
Deputy GM & Director
Mr. Chunshui Zhao

See Also

Discover More
What is the Intrinsic Value of one Anhui Huaren Health Pharmaceutical Co Ltd stock?

The intrinsic value of one Anhui Huaren Health Pharmaceutical Co Ltd stock under the Base Case scenario is 10.59 CNY.

Is Anhui Huaren Health Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 12.51 CNY, Anhui Huaren Health Pharmaceutical Co Ltd is Overvalued by 15%.

Back to Top